VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,122 | +33.6% | 28,900 | +38.9% | 0.09% | +11.4% |
Q1 2023 | $840 | +7.8% | 20,800 | 0.0% | 0.08% | +9.7% |
Q4 2022 | $779 | -99.9% | 20,800 | -16.1% | 0.07% | -5.3% |
Q3 2022 | $879,000 | +12.8% | 24,800 | +19.2% | 0.08% | +171.4% |
Q2 2022 | $779,000 | 0.0% | 20,800 | 0.0% | 0.03% | -70.8% |
Q1 2022 | $779,000 | -35.9% | 20,800 | -33.5% | 0.10% | -28.9% |
Q4 2021 | $1,215,000 | +73.3% | 31,300 | +80.9% | 0.14% | +28.6% |
Q3 2021 | $701,000 | +47.6% | 17,300 | +50.4% | 0.10% | +50.0% |
Q2 2021 | $475,000 | -30.9% | 11,500 | -29.0% | 0.07% | -27.1% |
Q1 2021 | $687,000 | +31.1% | 16,200 | +32.8% | 0.10% | -18.6% |
Q4 2020 | $524,000 | +52300.0% | 12,200 | +320.7% | 0.12% | +1080.0% |
Q4 2018 | $1,000 | -50.0% | 2,900 | 0.0% | 0.01% | -86.7% |
Q2 2018 | $2,000 | -50.0% | 2,900 | 0.0% | 0.08% | -62.7% |
Q1 2018 | $4,000 | +300.0% | 2,900 | +38.1% | 0.20% | +813.6% |
Q4 2017 | $1,000 | 0.0% | 2,100 | -58.0% | 0.02% | +2100.0% |
Q3 2017 | $1,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |